Citation Tools

Download PDFPDF

Original research
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

Download to a citation manager

Cite this article as:
Briot K, Portale AA, Brandi ML, et al
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension